DiaMedica Therapeutics Inc. SEC filings DMAC
DiaMedica Therapeutics Inc. has 427 filings in SEC EDGAR's recent list, going back to May 16, 2007. Its latest annual report, Form ARS, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 10, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 21, 2026 | May 20, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Other events
|
Jan 5, 2026 | Jan 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 18, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Aug 6, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 21, 2025 | Jul 21, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 17, 2025 | Jul 17, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2025 | May 15, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2025 | Mar 17, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 6, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 24, 2025 | Feb 20, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 26, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 26, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 23, 2024 | May 22, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2024 | Apr 5, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2024 | Mar 19, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 5, 2023 | Sep 3, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 21, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 21, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Other events
|
Jun 21, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 30, 2023 | May 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 22, 2023 | May 22, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 18, 2023 | May 17, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K/A |
Amended current report
Officer or director change
|
Mar 10, 2023 | Mar 1, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 6, 2023 | Mar 1, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Oct 26, 2022 | Oct 26, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 8-K |
Current report
Other events
|
Jul 6, 2022 | Jul 6, 2022 |
| 8-K |
Current report
Material agreement
|
Jun 29, 2022 | Jun 23, 2022 |
| 8-K |
Current report
Officer or director change
|
May 25, 2022 | May 23, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 19, 2022 | May 18, 2022 |
| 8-K |
Current report
Results of operations
|
May 4, 2022 | May 4, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2022 | Mar 14, 2022 |
| 8-K |
Current report
Other events
|
Feb 11, 2022 | Feb 11, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 27, 2021 | Sep 26, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 13, 2021 | Sep 13, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jul 16, 2021 | Jul 15, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 29, 2021 | Jun 29, 2021 |
| 8-K |
Current report
Results of operations
|
May 5, 2021 | May 5, 2021 |
| 8-K |
Current report
Other events
|
Apr 29, 2021 | Apr 29, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2021 | Mar 10, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2020 | Nov 4, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2020 | Aug 11, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 7, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 5, 2020 | Aug 5, 2020 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 3, 2020 | Jun 2, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
May 13, 2020 | May 13, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2020 | Mar 23, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 13, 2020 | Feb 11, 2020 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 11, 2020 | Feb 11, 2020 |
| 8-K |
Current report
Material agreement
|
Jan 3, 2020 | Dec 27, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2019 | Nov 13, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 30, 2019 | Oct 24, 2019 |
| 8-K |
Current report
Agreement ended, Results of operations
|
Aug 13, 2019 | Aug 12, 2019 |
| 8-K |
Current report
Officer or director change
|
Jun 21, 2019 | Jun 20, 2019 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 19, 2019 | Jun 19, 2019 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
|
Jun 4, 2019 | May 31, 2019 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 23, 2019 | May 22, 2019 |
| 8-K |
Current report
Results of operations
|
May 13, 2019 | May 13, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 19, 2019 | Mar 19, 2019 |
| 8-K |
Current report
Other events
|
Feb 26, 2019 | Feb 26, 2019 |
| 8-K |
Current report
Listing notice
|
Jan 9, 2019 | Jan 9, 2019 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 3, 2019 | Jan 3, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 11, 2018 | Dec 6, 2018 |
Showing 81 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DMAC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Minneapolis, MN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1401040
- Former names
- DiaMedica Inc. (until Mar 11, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.